CV Science

David Balayssac PharmD, PhD

Course and current status

Associate Dean of the faculty of pharmacy, Clermont-Ferrand, France (2021)

Associate professor and hopsital practitionner, Toxicology, faculty of pharmacy, Clermont-Ferrand, France (2008)

HDR, Université Clermont Auvergne, France (2018)

PhD of Toxicology, Université Clermont Auvergne, Clermont-Ferrand, France (2005)

Residency diploma of pharmacy, Université Clermont Auvergne, Clermont-Ferrand, France (2003)

PharmD, Université Clermont Auvergne, Clermont-Ferrand, France (2003)

Master degree of Toxicology, Université Paris V, Paris, France (2002)

MSc biological science applied to medicine, Université Clermont Auvergne, Clermont-Ferrand, France (2000)

Scientific summary

David Balayssac is co-authors of about 50 scientific publications in international journals (Support Care Cancer, Expert Opin Drug Saf., J Clin Med., BMJ Open, Neuropharmacology, Front Pharmacol., Pain, PLoS One, Subst Abus., World J Surg., Surg Endosc., J Neurosci. J Hum Lact., Surg Innov., Curr Pain Headache Rep., Neurotherapeutics, Neurosci Lett., Chemotherapy, Toxicology, Eur J Pharmacol., J Peripher Nerv Syst., Toxicol Lett.). Research activities are mainly focused on chemotherapy-induced peripheral neuropathies, both in animals and Humans, in order to understand the pathophysiology and identify new pharmacological targets. David Balayssac is coordinator of the IMI2 project NEURODERISK for the Université Clermont Auvergne. This project is focused on the identification of early and non-invasive biomarkers of peripheral neurotoxicity.